Pharmaceutical Executive Europe - Pharma news, strategy, sales & marketing, R&D, M&A, regulation, technology
 Home   Log-in   Register   Subscribe / Renew   e-Alerts   About Us   Media Kit   Contact   RSS  

CORPORATE STRATEGY FINANCE, M&A R&D REGULATORY, LEGAL SALES & MARKETING SUPPLY CHAIN, TECHNOLOGY

ADVERTISEMENT

Log-in
You are logged in as
Username:
Password:
Remember me so that I do not have to log in the next time I visit
Survey
How far behind the US would you say is the European biotech industry?
5-10 years
1-5 years
It's about equal
It's ahead!
5-10 years
18%
1-5 years
36%
It's about equal
27%
It's ahead!
18%
View Results
Thank you for voting
Previous StoryPlay / PauseNext Story
News update
18-Aug-08: Pfizer announces closure of Irish manufacturing site
Pfizer has announced that it is going to close its manufacturing site in Cork, resulting in the loss of 180 jobs.
18-Aug-08: Pfizer buys rights to Immunodrug technology
Pfizer is to pay $137 million for the use of Cytos Biotechnology's Immunodrug technology.
18-Aug-08: Abbott to promote Crestor in the US
Abbott has struck a deal with AstraZeneca to promote the cholesterol-lowering drug Crestor (rosuvastatin calcium) in the US.
14-Aug-08: Genentech reject Roche's offer
Genentech has turned down a buyout offer from its majority owner, Roche.
11-Aug-08: Bayer in generic fight with Sandoz
Bayer has filed a patent infringement lawsuit against Sandoz, the generic medication division of Novartis, related to the oral contraceptive YAZ.
Latest content from related sites...
Pharmaceutical Executive Magazine
Latest content from the Pharmaceutical Executive website:
GSK to Work with Valeant on Epilepsy Drug
Vytorin Comes Under Fire Yet Again
UCB Pharma to Rebrand as Specialty Company
AZ Adds an Electronic Component to Direct Mail
Fake Pharmacies and Brand Jacking on the Rise
Last updated on Fri Sep 05 20:11:41 EDT 2008
Pharmaceutical Technology Europe
Latest content from the Pharmaceutical Technology Europe website:
The victory is for India
Fraser Black — know your assets
Andrew Hughes from AstraZeneca — Singapore collaboration
Collaboration to discover anti-cancer compounds
Breaking the rules
Latest issue
Click here to view the latest issue
REFLECTOR
What's going on in Europe at the moment? Find out with PEE's regular columnist, Reflector.
Sales training
Sales Training for Real Behaviour Change
Beyond the blockbuster

What Can Big Pharma Learn from Mid-tier and Specialty Pharma?

Make This Page Your Home Page!
Click here